Sparking New Discoveries for Parkinson’s Disease
The Collaborative Research Network (CRN) is a first-of-its-kind global community of multidisciplinary and multi-institutional teams working together to spark new discoveries in Parkinson’s disease (PD) research. The CRN is a program of the Aligning Science Across Parkinson’s (ASAP) initiative, managed by the Coalition for Aligning Science and implemented by the Michael J. Fox Foundation.
Our Research Network
The ASAP CRN supports 67 research teams across 22 countries, focusing on critical areas such as functional genomics in Parkinson’s disease, neuro-immune interactions, circuitry and brain-body interactions, PD heterogeneity, and tool generation. With collaboration at its core, the CRN brings together hundreds of investigators to share expertise, findings, and tools in an effort to tackle challenges in the PD space. As a community, we promote standards for openness, real-world utility, and collective impact across scientific research.
An ASAP Program
An ASAP Program
The Aligning Science Across Parkinson’s (ASAP) initiative launched the CRN in 2020 to catalyze breakthroughs in PD research. ASAP fosters connections across the scientific community by supporting a variety of programs designed to enhance collaboration and promote sharing of scientific findings, tools, and technologies.
Impact
From the beginning, the CRN has been committed to providing resources, addressing research bottlenecks, and fostering innovation to build a thriving research ecosystem that advances Parkinson’s disease research.
Impact
From the beginning, the CRN has been committed to providing resources, addressing research bottlenecks, and fostering innovation to build a thriving research ecosystem that advances Parkinson’s disease research.
Latest CRN Highlights
Members of the CRN work diligently to advance our understanding of Parkinson’s disease. Learn more about recent CRN discoveries and achievements.
The End of the ‘One-Size-Fits-All’ Parkinson’s Diagnosis: Why 2026 Is the Year Neurology Goes High-Resolution
In a commentary published in Bio-IT World, ASAP Managing Director Sonya Dumanis shares how Parkinson's disease diagnosis and treatment is shifting away from broad symptom management towards a precision medicine approach grounded in molecular profiling, novel biomarkers, and global data-sharing.
ASAP Collaborative Research Network (CRN) Impact Report 2025-2026
As an extension of the ASAP CRN Impact Report 2020–2024, this report highlights the cross-cutting scientific themes, field-enabling resources, infrastructure efforts, and key discoveries accelerating breakthroughs in PD research across our Collaborative Research Network (CRN).
Endolysosomal Pathways in Parkinson’s Disease: Highlights from the 2025 Cell Biology of Parkinson’s Disease Conference
Read highlights from the 2025 Cell Biology of Parkinson’s Disease Conference that brought together investigators and trainees to discuss the intricacies of Parkinson’s disease at the cellular level.